Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Report includes call to action outlining steps Congress must take to maintain momentum.
A new analysis confirms the American Institute for Cancer Research’s tips for lowering the risk of breast, colorectal and lung cancers.
People over 70 have a heightened risk of cancer, yet they are under-represented in clinical trials of new drugs.
Palliative care specialists help patients find relief from pain, stress and treatment side effects.
In nearly 220,000 stores, tobacco companies must post signs “telling the truth about the deadly consequences of cigarette smoking.”
Part 2 in a series from the University of Colorado that unpacks the goals of the National Cancer Institute’s National Cancer Plan.
Responders may be able to discontinue immune checkpoint inhibitors after two years with no decrease in survival.
While expensive new drugs are developed, thousands of people can’t get a drug like cisplatin that costs as little as $6 a dose.
Cancer survivors make awesome advocates, and the summer 2023 issue of Cancer Health profiles several inspiring figures.
Products that protect skin and enlighten minds, including the lung-cancer memoir “Stage 5”
Early cancer detection is key to improving survival rates and reducing costs of treating cancer.
Plus: NCCN calls for solutions to the shortage that’s affecting common treatments for breast, blood, lung and prostate cancers.
The oral targeted therapy led to a 51% improvement in survival for patients with EGFR-mutated non-small-cell lung cancer.
Models based on personal risk may be more useful than those based on age and smoking history alone.
A nationwide shortage of cancer drugs is causing thousands of patients to experience delays in treatment.
However, deaths due to liver cancer in men and lung cancer in women are increasing in most countries.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.